本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Allogene Therapeutics Inc.

1.13
-0.0400-3.42%
盘前1.10-0.0300-2.65%08:37 EDT
成交量:733.66万
成交额:809.97万
市值:2.47亿
市盈率:-0.85
高:1.20
开:1.20
低:1.06
收:1.17
数据加载中...
2021/09/20

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/09/17

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/23

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/17

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/03

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/08/03

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/08/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/07/16

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/06/16

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/06/15

重要事件披露

8-K - Current report
2021/05/20

重要事件披露

8-K - Current report
2021/05/19

重要事件披露

8-K - Current report
2021/05/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/05

重要事件披露

8-K - Current report
2021/02/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals